The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.

Ahmad Husari, Atallah Beydoun, Amein Sheik Ammar, Joseph E. Maakaron, Ali Taher

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

We report an 85-year-old male, with history of interstitial pulmonary fibrosis (IPF), who was presented with progressive dyspnea, hypoxia, and anemia of 2 months duration. Six months before presentation, the patient was placed on Dabigatran etexilate (Dabigatran) (110 mg BID) for atrial fibrillation. His prior anemia workup included a negative upper endoscopy and colonoscopy. Bronchoscopy revealed copious amounts of bloody secretions. The bronchial tree was washed and Dabigatran was discontinued. The patient's medical condition improved and was subsequently discharged home. Our case illustrates the failure of current literature to predict the isolated bronchoalveolar bleed secondary to Dabigatran therapy.

Original languageEnglish (US)
Pages (from-to)81-82
Number of pages2
JournalJournal of thrombosis and thrombolysis
Volume35
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.'. Together they form a unique fingerprint.

Cite this